INSIGHTS ON CLINICAL TRIAL DESIGN
-
![The Real Payoff]( "The Real Payoff Of Reusable IRT/RTSM System Design")
The Real Payoff Of Reusable IRT/RTSM System DesignBy utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.
-
![GettyImages-1363748446 heart and lung disease]( "Capital Efficiency In Cardiovascular Outcomes Trials")
Capital Efficiency In Cardiovascular Outcomes TrialsNew modeling shows aligning clinical and manufacturing operations in heart trials can cut costs, speed timelines, and boost expected program value.
-
![castor hype webinar]( "From Hype To Health: How Sword Built Evidence That Scales")
From Hype To Health: How Sword Built Evidence That ScalesA candid look at balancing resource constraints with rigorous clinical strategy to earn trust, reimbursement, and real growth.
-
![GettyImages-2170642314-year 2025]( "Five Predictions For Clinical Research In 2025")
Five Predictions For Clinical Research In 2025In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.
-
How To Improve Patient ID And Retention In Chronic Disease Trials4/23/2026
Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.
-
The Golden Era Of GLP-1 Drugs10/8/2024
As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.
-
How Will The Ophthalmologist Shortage Impact Your Next Study?1/29/2025
With a shortage of ophthalmologists affecting patients in both ophthalmic and non-ophthalmic clinical trials, the industry is looking for new solutions to ensure trial success and efficiency.
-
Beyond Go-Live: The True RTSM Quality Test3/25/2026
Go‑live is only the beginning. This clip highlights how RTSM performance evolves over years of real‑world use — and why long‑term flexibility is just as important as a clean launch.
-
Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors7/17/2026
Biomarkers and other specialty lab samples are among the most fragile parts of clinical trial execution, but what makes them so vulnerable to mishandling, and what are the effects?
CLINICAL TRIAL DESIGN SOLUTIONS
-
![clinical-trials-patients-GettyImages-1629549075]( "Develop Site-Centric Protocols To Optimize Enrollment")
Optimize clinical trial protocols by aligning scientific goals with real-world site operations. Improve enrollment, reduce site burden, and minimize costly amendments through data-driven design.
-
![iStock-493302504-scientist-lab-development]( "Pre-Formulation And Material Sciences")
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
![GettyImages-639668490 patient]( "Scout: Beyond The Numbers")
Patient retention has benefits beyond what’s reflected in a data set. Explore some of the ways clinical trial participation can have a transformative impact on patients and their families.
-
![GettyImages-1311429557-vaccine-shot]( "The #1 Rated Leader In DCT Now Offers The Vaccine Pathway")
Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.
-
![GettyImages-1295492925-computer-future-data-research-lab]( "Isotope Labelling")
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
